STING1 and cancer: A previous study has suggested that chemotherapy and radiation enhance the responsiveness of cancers to ICB therapy through the release of pathogen associated molecular patterns (PAMPs) and damage associated molecular patterns (DAMPs), which drive TLR-dependent [177] and stimulator of interferon gene (STING)-dependent DC activation.